40
Participants
Start Date
March 1, 2019
Primary Completion Date
November 30, 2022
Study Completion Date
December 30, 2022
Ambroxol
"Ambroxol Hydrochloride therapy will be dosed up to 600 mg/day divided to twice a day starting 150 mg for the first month, 300 mg for the following month and 600 mg for the following month.~The study was conducted in accordance with the provisions of the Declaration of Helsinki, Good Clinical Practice guidelines, and local laws and regulations."
Shaare Zedek Medical Center, Jerusalem
Shaare Zedek Medical Center
OTHER